🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

27 recruiting trials

for Acute-On-Chronic Liver Failure

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF NCT03920618NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device NCT06079021NA1 site📍 Edegem University Hospital, Antwerp · Tests: CytoSorb Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease NCT03773887NA1 site📍 Lille University Hospital, Lille · Tests: collection of liver biopsies collection of blood samples The Effects of Double Plasma Molecular Adsorption System in Acute on Chronic Liver Failure Patients NCT05030571NA1 site📍 Bangkok Chulalongkorn University · Tests: DPMAS, standard treatment Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy NCT06831565NA1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: ROTEM ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF NCT07329036NA1 site📍 Prague Institute for Clinical and Experimental Medicine · Tests: The artificial liver support system (ALSS) - DPMAS/TPE Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure NCT07275554n/a1 site📍 Jinan Qilu Hospital of Shandong University CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336n/a28 sites📍 Klagenfurt📍 Vienna📍 Aachen CytoSorbents, Inc · Tests: CytoSorb F573 for Injection for the Treatment of Liver Injury/Failure NCT05689645Phase 210 sites📍 Beijing📍 Qingyuan📍 Shiyan Beijing Continent Pharmaceutical Co, Ltd. · Tests: F573 for injection, Sterilizing water for injection Risk Factors Affecting MSC Efficacy in ACLF Patients NCT07198854n/a1 site📍 Guangzhou Sun Yat-sen University · Tests: Not applicable- observational study Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis NCT07438288n/a3 sites📍 Singapore📍 Singapore📍 Singapore Singapore General Hospital · Tests: Observation A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device. NCT07347275NA1 site📍 London Yaqrit Ltd · Tests: Standard of Care (Investigator Choice), DIALIVE 2.0 liver dialysis Device plus available Standard of Care Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients NCT06916585Phase 21 site📍 Shenzhen Shenzhen Third People's Hospital · Tests: AS1501 for injection Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs NCT04613921n/a106 sites📍 Los Angeles📍 Aurora📍 Tampa European Foundation for Study of Chronic Liver Failure · Tests: Observational Protocol Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis NCT06562803NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: double plasma cytokine adsorption system with sequential low-dose plasma exchange, plasma exchange Study About Hepatic Toxins Kinetic and Evaluation of Organ Damage in Acute on Chronic Liver Failure (ACLF) Patients NCT06837766n/a3 sites📍 Ancona📍 Bologna📍 Milan IRCCS Azienda Ospedaliero-Universitaria di Bologna SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury NCT06173947n/a1 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: FibroScan® Expert 630 Fecal Microbiota Transplantation for Liver Failure NCT05170971NA1 site📍 Ningbo Ningbo Medical Center Lihuili Hospital · Tests: fecal microbiota transplantation Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults NCT05727722Phase 11 site📍 Shanghai RenJi Hospital · Tests: a single course of micro-encapsulated hepatocytes intraperitoneal transplantation therapy A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial). NCT05895136Phase 29 sites📍 Clichy📍 Aachen📍 Münster European Foundation for Study of Chronic Liver Failure · Tests: Human albumin, Enoxaparin, Standard medical treatment Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study NCT06948565n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon · Tests: observational study Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure NCT05985863Phase 1, Phase 21 site📍 Beijing Beijing 302 Hospital · Tests: standard medical treatment, Placebo, hUC-MSC, hUC-MSC_Prolonged Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease NCT04578301n/a1 site📍 Bonn University Hospital, Bonn · Tests: No Intervention A-TANGO Phase 2 Study NCT06890039Phase 21 site📍 London Yaqrit Ltd · Tests: Placebo, TAK-242, G-CSF (Filgrastim) Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure NCT04310787n/a1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure NCT05989958Phase 1, Phase 21 site📍 Beijing Hexaell Biotech Co., Ltd. · Tests: HepaCure, DPMAS and LPE Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF NCT04597164n/a1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: Artificial liver support system
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy